A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride in Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation.
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Prucalopride (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Shire
- 01 Feb 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 11 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 12 May 2012 Additional trial location added as reported by European Clinical Trials Database.